A carregar...
Paliperidone extended-release: does it have a place in antipsychotic therapy?
Paliperidone (9-hydroxy-risperidone), the active metabolite of risperidone, was approved for treating schizophrenia worldwide in 2006 as paliperidone extended-release (PER), and became the first second-generation antipsychotic specifically licensed for treating schizoaffective disorder in 2009. Howe...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3063117/ https://ncbi.nlm.nih.gov/pubmed/21448450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S17266 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|